The 12 Most Unpleasant Types Of ADHD Medication Pregnancy People You Follow On Twitter > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is challenging for women with the condition. There aren't many studies on how to get adhd meds without diagnosis long-term exposure may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the advantages of taking them against the potential risks to the fetus. The doctors don't have the information to give clear advice however they can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at higher risk of fetal malformations, or structural birth defects. Researchers conducted a massive population-based study of case control to assess the frequency of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was accurate and to minimize any bias.

The research conducted by the researchers was not without limitations. Most important, they were unable to distinguish the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medication for adhd and depression or if they were affected by comorbidities. The researchers did not look at long-term outcomes for the offspring.

The study did reveal that infants whose mothers took ADHD medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had taken off their medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, when possible, help them develop strategies to improve coping skills which can reduce the effects of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh their knowledge, the experiences of other doctors, and what research says on the topic as well as their own best judgment for each individual patient.

In particular, the issue of potential risks to the baby can be tricky. Many of the studies on this topic are based on observational data rather than controlled research, and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

Conclusion A few studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not established a link. The majority of studies show a neutral, or even slight negative impact. In every case it is imperative to conduct a thorough analysis of the benefits and risks must be performed.

For many women with ADHD who suffer from ADHD, the decision to discontinue medication can be difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. The loss of medication can also affect the ability to safely drive and perform work-related tasks, which are vital aspects of everyday life for those suffering from ADHD.

She suggests women who are uncertain about whether to continue or discontinue medication due to their pregnancy, consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and on the advantages of continuing the current treatment plan. It will also help a woman feel confident about her decision. It is important to note that some medications are able to pass through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be transferred to the child.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about what impact the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Researchers used two massive data sets to study over 4.3 million pregnancies and determine if stimulant medication use increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester adhd medication not working medication exposure was associated with slightly higher risk types of adhd medication certain heart defects, like ventriculoseptal defect.

The authors of the study found no association between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The findings are in line with previous studies that have shown a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk was higher during the latter part of pregnancy, as many women decide to stop taking their ADHD medication.

Women who took ADHD medication during the first trimester were more likely to require a caesarean delivery or have an insufficient Apgar after delivery, and had a baby that required help breathing when they were born. However the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical conditions that could have contributed to these findings.

The researchers hope their research will aid in the clinical decisions of physicians who see pregnant women. They suggest that although discussing the benefits and risks is important, the decision to stop or continue treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it isn't an option to consider due to the high prevalence of depression and other mental health problems among women who are pregnant or recently post-partum. Further, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties getting used to life without them following the birth of their baby.

Nursing

It can be a stressful experience to become a mom. Women who suffer from ADHD who have to manage their symptoms while attending doctor appointments as well as getting ready for the arrival of a child and adapting to new routines in the home can experience severe challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at a low level. However, the frequency of exposure to medications by the newborn can vary depending on dosage, frequency it is taken and the time of the day the medication is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn is not fully comprehended.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the lack of research. This is a difficult decision for the patient, who must balance the benefits of continuing her medication against the potential risks to the foetus. Until more information becomes available, doctors may inquire about pregnant patients whether they have a background of ADHD or if they plan to take medication in the perinatal period.

Many studies have shown that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. In the end, more and more patients choose to do so and after consulting with their doctor, they have discovered that the benefits of keeping their current medication exceed any risk.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the root cause and learn about treatment options and reinforce existing coping strategies. This should involve a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a plan for management for both the mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.